Completo

Introduction. The diabetes mellitus type 2 (T2D) burden is rising worldwide, and in Mexico it has been the leading cause of death since 2000. Improved life expectancy of people living with HIV (PLWH) have led to an increase in chronic diseases such as T2D in such population. Estimates of T2D prevalence among HIV-infected adults are lacking, thus we assessed the annual incidence and prevalence of T2D among PLWH in Mexico. Material and Methods. A retrospective analysis using cohort data of adults receiving care for HIV at the INCMNSZ between 2000-2017 by performing a series of annually repeated cross-sectional analysis to estimate the annual prevalence and incidence of T2D among all people actively receiving care each year, during the study period. Results. During the period of the study, 3,338 patients were included and 123 were identified as diabetic at the end of follow-up. The annual prevalence of T2D among people receiving care for HIV increased from 2.4% in 2000 to 4.5% in 2017; the median age of T2D diagnosis was 42.15 years after a median of 7.45 years of HIV diagnosis. Also, overall comorbidities were more common in T2D patients (4 vs 1, p<0.001) when compared to non-T2D from which non-AIDS defining events were more frequent among people with diabetes (3 vs 1, p<0.001). Discussion. Our findings revealed that among a population of adults receiving care for HIV at the INCMNSZ, T2D was a relatively infrequent comorbidity but with a high burden of comorbidities.

Palabras clave: Antiretroviral comorbidity diabetes mellitus HIV infection prevalence

2018-08-22   |   1,129 visitas   |   Evalua este artículo 0 valoraciones

Vol. 9 Núm.4. Mayo-Julio 2018 Pags. 308-314 Rev Med MD 2018; 9(4)